Tickers in this article: GILD
Gilead Sciences says Selonsertib, a new drug for treating NASH, a type of liver disease, failed Phase 3 trials.
02/12/19 - 04:24 PM EST
It's that time of year again. It's time for open enrollment. What you need to know about the Medicare Advantage plans to save you money.
12/20/18 - 07:34 AM EST
By Anders Keitz
Here's what you need to know now for Friday, Sept. 21.
09/21/18 - 07:30 PM EDT
Here's what you need to know now for Thursday, Sept. 20.
09/20/18 - 07:30 PM EDT
Here's what you need to know for Wednesday, Sept. 18.
09/19/18 - 07:30 PM EDT
There is no denying the obvious consumer demand. There is no denying legal trends.
09/13/18 - 09:15 AM EDT
Here's what you need to know now for Monday, Sept. 10.
09/10/18 - 08:00 PM EDT
By Tip Ranks
Biotechs are known for wild tears. Investors, you'll want to consider these drug makers.
09/05/18 - 08:30 AM EDT
By Tip Ranks
Follow the experts. These biotech stocks have Wall Street's best analysts getting bullish.
08/13/18 - 08:00 AM EDT
Tickers in this article: INNMF
Innate Immunotherapeutics of Australia is the biopharmaceutical company at the center of the insider trading charges leveled against New York Rep. Chris Collins.
08/09/18 - 10:40 AM EDT
Private equity has increased its interest in healthcare related plays, as the LifePoint deal suggests..
07/23/18 - 08:00 PM EDT
Tickers in this article: BIIB
Positive readings from the biotech giant's Alzheimer's drug could drive the stock to as high as $393.
07/20/18 - 08:35 AM EDT
Drug pricing remains front and center as healthcare companies start reporting quarterly results.
07/20/18 - 07:30 AM EDT
By Tom Bemis
Some beaten up biotech names are finally coming back to life. Here's a look at the technical analysis.
07/18/18 - 06:59 AM EDT